Clonidine Hci Injection, Solution
Product Images NDC 51662-1346

8 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clonidine Hci (NDC 51662-1346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse)

Adverse (Adverse)
Table showing adverse events in patients treated with Clonidine compared to placebo. It lists the number and percentage of patients experiencing events such as hypotension, dry mouth, nausea, somnolence, dizziness, confusion, and others in both Clonidine and placebo groups.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
A data table comparing volumes of Clonidine Hydrochloride Injection at 500 mcg/mL with corresponding volumes of 0.9% Sodium Chloride for Injection, USP, and the resulting final Clonidine Hydrochloride Injection concentration at 100 mcg/mL. It displays dilution amounts from 1 mL to 10 mL Clonidine with increasing volumes of sodium chloride, showing final concentrations ranging from 500 mcg/5 mL to 5000 mcg/50 mL.*
FDA Label Image

Labeled Vial And Box (Labeled Vial And Box)

Labeled Vial And Box (Labeled Vial And Box)
CLONIDINE HCI Injection 1000 mcg/10 mL (100 mcg/mL) in a single-dose vial with a blue cap. The vial label and outer carton prominently display the concentration and note that it is preservative-free and labeled for epidural injection. The product is Rx only.*
FDA Label Image

Spl1 (Spl 1)

Spl1 (Spl 1)
A text panel noting that the 500 mcg/mL strength product should be diluted prior to use in an appropriate solution.*
FDA Label Image

Spl2 (Spl 2)

Spl2 (Spl 2)
Text panel from CLONIDINE HCl injection (epidural clonidine) indicating it is not recommended for obstetrical, postpartum, or peri-operative pain management due to risks of hemodynamic instability, hypotension, and bradycardia, but noting rare cases may have benefits outweighing risks.*
FDA Label Image

Serialized Box (Serialized Box Labeling)

Serialized Box (Serialized Box Labeling)
CLONIDINE HCl Injection 100 mcg/10 mL (100 mcg/mL) carton by West-Ward Pharmaceuticals. The packaging indicates it is a single dose vial, preservative-free, labeled for epidural injection. Distributed by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Clonidine HCl with molecular formula C9H9Cl2N3·HCl and molecular weight 266.56, showing detailed atomic bonds and arrangement.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for CLONIDINE HCI Injection, 100 mcg/mL (1000 mcg/10 mL), single-dose vial. The label indicates preservative-free solution for epidural injection. It includes storage instructions at 25°C (77°F) with permitted excursions, manufacturer details (Hikma Farmacêutica, Portugal), and distributor (West-Ward Pharmaceutical, Easton, NJ). The label also contains barcode and lot/expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.